EE623 Cost-Minimization Analysis of a High Concentration Adalimumab Biosimilar: The Greek Context
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.862
https://www.valueinhealthjournal.com/article/S1098-3015(22)03066-2/fulltext
Title :
EE623 Cost-Minimization Analysis of a High Concentration Adalimumab Biosimilar: The Greek Context
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03066-2&doi=10.1016/j.jval.2022.09.862
First page :
Section Title :
Open access? :
No
Section Order :
10405